Polysaccharide preparations lacking substantial anticoagulant activity are provided herein. Methods of making and using such preparations are provided.
From Description:
The preparations described herein can be administered to a subject in single or multiple doses to treat or prevent a metastatic or cancerous disorder....
Also - The preparations described herein can also be used to treat inflammatory, autoimmune, f[iota]brotic, fibroproliferative, atopic, or angiogenic disorders.